New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...
This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...
The LUNG FORCE Run/Walk provides critical funds for lifesaving lung cancer research, early detection initiatives and ...
Lung cancer is the leading cause of cancer deaths, but there is hope! More Americans than ever are surviving lung cancer. In ...
Recent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may significantly impact ...
A new strategy to treat a common form of lung cancer focuses on a protein whose loss makes it harder for the body to repair ...
We quantified the proportion of diagnoses of pulmonary fibrosis (PF) among 25 136 people with lung cancer and 250 583 matched ...
Cancer deaths are down in the U.S., but the disease is taking hold in younger populations, likely fueled by obesity, alcohol ...
In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.
The toxicity of lung cancer treatment has traditionally been discussed in terms of physical symptoms, but there is a growing focus on financial toxicity, time toxicity, and other effects on well-being ...
Lung cancer is tied to tobacco smoking in the public consciousness, but a significant proportion of cases are driven by ...
Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback